Check Out What Whales Are Doing With IBM Today, Benzinga 's options scanner spotted 10 uncommon options trades for IBM. This isn't normal. The overall sentiment of these big-money traders is split between 20% bullish and 60%, bearish. Out of ... 05/31/2024 - 9:02 am | View Link
IBM (IBM) Dips More Than Broader Market: What You Should Know The latest trading session saw IBM (IBM) ending at $165.63, denoting a -0.85% adjustment from its last day's close. The stock's change was less than the S&P 500's daily loss of 0.6%. Meanwhile, the ... 05/30/2024 - 10:45 am | View Link
Watsonx Can Help IBM Stock Gain Lost Ground IBM posted mixed Q1 2024 results last month, with revenue growing just 1.5% year-over-year to $14.46 billion, missing estimates as the consulting and infrastructure ... 05/29/2024 - 10:00 pm | View Link
IBM Options Trading: A Deep Dive into Market Sentiment In terms of liquidity and interest, the mean open interest for IBM options trades today is 1476.44 with a total volume of 1,484.00. In the following chart, we are able to follow the development of ... 05/29/2024 - 6:02 am | View Link
IBM: Persistent Challenges IBM's struggling business in cloud, big data, and AI sectors, weak revenue growth, unclear margin trends, and other concerns make it a stock to avoid. See more here. 05/27/2024 - 8:00 pm | View Link
PBN asked Domestic Violence Action Center CEO Monique Ibarra about trends of abuse in Hawaii, and what such implications mean for the organization and those it serves statewide.
The company creates skincare products, including cleansing creams, serums, moisturizers and more, utilizing botanicals such as olena, kalo and lilikoi.
The drug is approved for breast cancer, but the FDA could remove its approval in bladder cancer. It failed a late-stage trial earlier this year in a type of lung cancer.